Targeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies
Author:
Funder
Novo Nordisk Fonden
Kræftens Bekæmpelse
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/article/10.1007/s40265-018-1003-6/fulltext.html
Reference81 articles.
1. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9:722–8.
2. Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72:279–90.
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–54.
4. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. In: Presented in part at the 40th annual meeting of the american society of hematology, held in Miami Beach, FL, December 4–8, 1998, 1999, vol. 94, pp. 1840–7.
5. Niemann CU, Wiestner A. B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol. 2013;23:410–21.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What a Clinician Needs to Know About Genome Editing: Status and Opportunities for Inborn Errors of Immunity;The Journal of Allergy and Clinical Immunology: In Practice;2024-05
2. Discovery of novel dual Bruton’s tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis;Bioorganic & Medicinal Chemistry;2023-12
3. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06
4. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies;Experimental Hematology & Oncology;2023-10-16
5. Tyrosine kinase inhibitors and atherosclerosis: A close but complicated relationship;European Journal of Pharmacology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3